NARI Insider Trading

Insider Ownership Percentage: 10.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $37,943,968.16

Inari Medical Insider Trading History Chart

This chart shows the insider buying and selling history at Inari Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20M-$10M$0$10M$20MTotal Insider BuyingTotal Insider Selling

Inari Medical Share Price & Price History

Current Price: $79.97
Price Change: +0.30 (1.20%)
As of 02/19/2025 01:00 AM ET

This chart shows the closing price history over time for NARI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$79.97Closing price on 04/17/25:

SEC Filings (Institutional Ownership Changes) for Inari Medical (NASDAQ:NARI)

90.98% of Inari Medical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NARI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$349Mbought$298MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200M$0$200MTotal InflowsTotal Outflows
Inari Medical logo
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Read More on Inari Medical

Today's Range

Now: $79.97
Low: $79.97
High: $79.97

50 Day Range

MA: $79.96
Low: $79.88
High: $79.97

52 Week Range

Now: $79.97
Low: $36.73
High: $79.99

Volume

N/A

Average Volume

1,310,252 shs

Market Capitalization

$4.68 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.02

Who are the company insiders with the largest holdings of Inari Medical?

Inari Medical's top insider investors include:
  1. Donald B Milder (Director)
  2. William Hoffman (Director)
  3. Andrew Hykes (CEO)
  4. Thomas Tu (Insider)
  5. Mitch C Hill (CFO)
  6. Rebecca Chambers (Director)
Learn More about top insider investors at Inari Medical.